Mylan (MYL) Launches Generic Bonviva Tabs (RHHBY) in Italy & the U.K.
Tweet Send to a FriendGet Alerts MYL Hot Sheet
Trade MYL Now!
Mylan Inc. (Nasdaq: MYL) announced that its UK and Italy-based subsidiaries have launched Ibandronic Acid Film Coated Tablets POM, 150 mg. This product is the generic version of Roche's (OTCBB: RHHBY) Bonviva Tablets, a treatment for osteoporosis.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- EMA Approves MAA for Gilead's (GILD) Sofosbuvir
- Sanofi (SNY), Regeneron (REGN) Report Publication of Positive Dupilumab Phase 2a Data
- Echo Therapeutics (ECTE) Gets IRB Approval for Symphony CGM System
Create E-mail Alert Related Categories
Corporate News, FDALogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

Down)